Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Immunogenicity Study of Inactivated EV71 Vaccine Produced in Vero Cells With Adjuvant AlPO4 in Children: Extension Study of Protocol CT-EV-21

NCT04072276 is registered in ClinicalTrials.gov with Medigen Vaccine Biologics Corp. as lead sponsor.

NCT NCT04072276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04072276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Immunogenicity Study of Inactivated EV71 Vaccine Produced in Vero Cells With Adjuvant AlPO4 in Children: Extension Study of Protocol CT-EV-21
Lead sponsor
Medigen Vaccine Biologics Corp.
Phase
Observational
Overall status
Completed
Start date
August 15, 2019
Completion date
December 11, 2021
Enrollment
227 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

enterovirus 71 human